Completed
NCT Number: NCT00212368
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
1 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Wilson's disease(adult,infant,pregnant woman)
Exclusion criteria
- acute hepatitis
- malignant tumor
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Nobelpharma
Industry
Registry information
Official study title
Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Important dates
- Study start
- 2004
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Sep 21, 2005
- Registry last updated
- Sep 10, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.